Vnitr Lek 2026, 72(2):99-103 | DOI: 10.36290/vnl.2026.021
Hypertension in women and men
- Centrum preventivní kardiologie, II. interní klinika LF a FN v Plzni, UK v Praze
This paper summarizes current knowledge on the epidemiology, diagnosis, treatment, and the potential development of target organ damage in hypertension in women and men, with an emphasis on sex-related differences, based on current clinical guidelines. Women have a lower prevalence of hypertension at a younger age; however, after menopause, prevalence may equal or even exceed that in men. Women with high-normal blood pressure may be more likely to develop hypertension than men. Compared with men, women may be more susceptible to hypertension-related target organ damage, and hypertension in women may be associated with a higher risk of ischemic heart disease and stroke. In both sexes, the cornerstone of therapy consists of lifestyle interventions and pharmacological treatment in accordance with current guidelines (ACE inhibitors/angiotensin receptor blockers, diuretics, calcium channel blockers, and beta-blockers), with specific exceptions during pregnancy and pregnancy planning. The management of hypertension in women must take into account reproductive plans, the possibility of pregnancy, and menopause-related changes. A personalized approach and the implementation of the most recent guidelines may improve cardiovascular prognosis. Further research is needed to elucidate sex differences in hypertension.
Keywords: hypertension, intersex difference, pregnancy, pharmacotherapy, hormonal treatment, menopause, guidelines.
Accepted: March 25, 2026; Published: April 8, 2026 Show citation
References
- McEvoy JW, McCarthy CP, Bruno RM, et al., ESC Scientific Document Group, 2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO), European Heart Journal. 2024(45);38:3912-4018. Available from: .
- Kreutz R, Brunström M, Burnier M, et al. 2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension, Eur J Intern Med. 2024;126:1-15. Available from: .
Go to original source... - Cífková R, Bruthans J, Wohlfahrt P, el at. The prevalence of major cardiovascular risk factors in the Czech population in 2015-2018. The Czech post-MONICA study. Cor Vasa. 2020;62(1):6-16. Available from: .
Go to original source... - Benešová K, Jarkovský J, Klika P, et al. Hypertenze v populaci ČR. Národní zdravotnický informační portál [online]. Praha: Ministerstvo zdravotnictví ČR a Ústav zdravotnických informací a statistiky ČR, 2023 [cit. 2025-11-23]. Available from: http://www.nzip.cz/data/1663-hypertenze-otevrena-data. ISSN 2695-0340.
- Yeo WY, Abraham R, Surapaneni AL, et al. Sex Differences in Hypertension and Its Management Throughout Life. Hypertension. 2024;81(11):2263-2274. Available from: .
Go to original source... - Fryar CD, Ostchega Y, Hales CM et al. Hypertension prevalence and control among adults: United States, 2015-2016. NCHS Data Brief. 2017;289:1-8.
- EUGenMed Cardiovascular Clinical Study Group. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J. 2016;37:24-34. Available from: .
Go to original source... - Ji H, Niiranen TJ, Rader F, et al. Sex Differences in Blood Pressure Associations With Cardiovascular Outcomes. Circulation. 2021;143(7):761-763. Available from: .
Go to original source... - Laughlin GA, Barret-Connor E, Kritz-Silverstein D et al. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab. 2000;85(2):645-651. Available from: .
Go to original source... - Ohldieck AE, Kringeland E, Midtbø H, et al. High-normal blood pressure in midlife is a stronger risk factor for incident hypertension 26 years later in women than men: the Hordaland Health Study. Blood Press. 2023;32(1):2179337. Available from: .
Go to original source... - Gerdts E, Izzo R, Mancusi C, et al. Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network). Int J Cardiol. 2018;258:257-61. Available from: .
Go to original source... - Izzo R, Losi MA, Stabile E et al. Development of left ventricular hypertrophy in treated hypertensive outpatients: The Campania Salute Network. Hypertension. 2017;69:136-42. Available from: .
Go to original source... - Gerdts E, Oikarinen L, Palmieri V, et al. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Hypertension. 2002;39:739-43. Available from: .
Go to original source... - Gerdts E, de Simone G. Hypertension in Women: Should There be a Sex-specific Threshold? Eur Cardiol 2021;16:e38. Available from: .
Go to original source... - Asirwatham A, Oliphant M, Kovell AC, et al. Secondary hypertension diagnosis and management among pregnant patients: a review, Am J Obstet Gynecol MFM. 2025;12:101813. Available from: .
Go to original source... - Gorostidi M, Vinyoles E, Banegas J, et al. Prevalence of white-coat and masked hypertension in national and international registries. Hypertens Res. 2015;38(1)1-7. Available from: https://doi.org/10.1038/hr.2014.149>.
Go to original source...
Go to PubMed... - Yin X, Paige E, Tian M, et al. The proportion of dietary salt replaced with potassium-enriched salt in the SSaSS: implications for scale-up. Hypertension. 2023;80:956-65. Available from: .
Go to original source... - Liu F, Liu Y, Sun X,et al. Race-and sex-specific association between alcohol consumption and hypertension in 22 cohort studies: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2020;30(8):1249-1259. Available from: .
Go to original source... - Cífková R. Farmakoterapie hypertenze v těhotenství. Klin Farmakol Farm. 2023;37(2):59-63. Available from: .
Go to original source... - Melloni C, Berger JS, Wang TY, et al. Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ Cardiovasc Qual Outcomes. 2010;3(2):135-142. Available from: .
Go to original source... - Turnbull F, Woodward M, Neal B et al. Blood Pressure Lowering Treatment Trialists' Collaboration. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J. 2008;29(21):2669-2680. Available from: .
Go to original source... - Gueyffier F, Boutitie F, Boissel JP, et al. The INDANA Investigators. The effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. Results from a meta-analysis of individual patient data randomised controlled trials. Ann Inter Med. 1997; 126(10):761-767. Available from: .
Go to original source... - Klungel OH, De Boer A, Paes AHP, et al. Sex differences in the pharmacological treatment of hypertension: a review of population-based studies. J Hypertens. 1997;5(6):591-600. Available from: .
Go to original source... - August P, Oparil S. Hypertension in women. J Clin Endocrinol Metab. 1999; 84(6):1862-1866. Available from: .
Go to original source... - Lewis CE. Characteristics and treatment of hypertension in women: a review of the literature. Am J Med Sci. 1996;311(4):193-199. Available from: .
Go to original source... - Bugiardini R, Yoon J, Kedev S, et al. Prior Beta-Blocker Therapy for Hypertension and Sex-Based Differences in Heart Failure Among Patients With Incident Coronary Heart Disease. Hypertension. 2020;76(3):819-826. Available from: .
Go to original source... - Desbiens LC, Khelifi N, Wang YP, et al. Thiazide Diuretics and Fracture Risk: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. JBMR Plus. 2022;6(11):e10683. Available from: .
Go to original source... - Arnautu AM, Nimigean VR, Nacea-Radu AC, et al. Menopausal Hormone Therapy-Risks, Benefits and Emerging Options: A Narrative Review Int. J. Mol. Sci 2025;26(22): 11098; Available from: .
Go to original source... - Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med 2023;389:107-117. Available from: .
Go to original source... - https://www.ema.europa.eu/en/medicines/human/referrals/testosterone-containing-medicines.




